Safer antibiotic dosing could protect kidneys in cystic fibrosis patients

This study tested two common IV antibiotics, tobramycin and colistin, in 51 adults with cystic fibrosis to find the safest and most effective way to treat lung infections. Researchers compared a new, less frequent dosing schedule for colistin to standard care, aiming to reduce kidney damage while still fighting the infection. The goal is to improve long-term treatment safety for people with cystic fibrosis.